stockrowHarmony Biosciences Holdings, Inc. (HRMY) vs Replimune Group, Inc. (REPL)
- Harmony Biosciences Holdings, Inc. HRMY 33.04 +1.76%
- Replimune Group, Inc. REPL 21.72 +8.49%
Harmony Biosciences Holdings, Inc. and Replimune Group, Inc. are both Biotechnology companies. Harmony Biosciences Holdings, Inc. and Replimune Group, Inc. are of similar size ($1.9B and $1.9B). Replimune Group, Inc. has negative trailing earnings, so its P/E is not meaningful; Harmony Biosciences Holdings, Inc. trades at 10.7×. Harmony Biosciences Holdings, Inc. has the higher net margin (18.1% vs 0.00%) and the higher return on invested capital (30.5% vs −928.3%). Across the 14 metrics below, Harmony Biosciences Holdings, Inc. leads on 13 and Replimune Group, Inc. on 1.
Valuation
Profitability
| Metric | HRMY | REPL | Biotechnology median |
|---|---|---|---|
| Gross margin | 74.03% | 0.00% | 68.51% |
| Operating margin | 22.17% | 0.00% | 0.00% |
| Net margin | 18.05% | 0.00% | 0.00% |
| Free cash flow margin | 32.65% | 0.00% | 0.00% |
| Return on equity | 18.73% | (115.80%) | (51.96%) |
| Return on assets | 13.30% | (71.01%) | (46.06%) |
| Return on invested capital | 30.45% | (928.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack